Navigation Links
Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference

LOS ANGELES--(BUSINESS WIRE)--Apr 16, 2007 - Introgen Therapeutics, Inc. (NASDAQ:INGN) reported updated ADVEXIN(R) biomarker data over the weekend in Los Angeles, California at the Annual Meeting of the American Association for Cancer Research.

Abnormality of the p53 tumor suppressor is one of the most common and fundamental molecular defects in cancer. ADVEXIN's mechanism of action is targeted to restoring p53 tumor suppressor function and the detection of abnormal p53 is a logical predictive biomarker for ADVEXIN efficacy. In a study of 28 recurrent head and neck cancer patients in Phase 2 clinical trials, abnormal p53 was shown to correlate with increased survival and tumor responses following ADVEXIN treatment.

The median survival of patients with tumors expressing the abnormal p53 biomarker was 11.6 months compared to only 3.5 months in patients whose tumors had normal p53. The association between the abnormal p53 biomarker and increased survival following ADVEXIN therapy was highly statistically significant (p=0.0007).

The abnormal p53 biomarker was also associated with a statistically significant increase in tumor responses to ADVEXIN therapy. A reduction in tumor size was observed in 40 percent of patients with the abnormal p53 biomarker compared to none (zero percent) of patients with p53 normal tumors. In addition, tumor growth control lasting for a minimum of two treatment cycles was observed in 75 percent of patients with abnormal p53 tumors compared to 27 percent of patients with a normal p53 biomarker. Both the increased reduction in tumor size and tumor growth control associated with the abnormal p53 biomarker were statistically significant (p=0.02).

Importantly, patients with abnormal p53 tumors are known to have poor responses and survival following standard treatments. These patients have the greatest need for new therapies and they achieved the most benefit from ADVEXIN t
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
2. Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241 in Patients With Advanced Solid Tumors
3. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
4. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
5. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
8. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
9. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
10. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
11. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
Post Your Comments:
(Date:4/28/2015)... 28, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ... Quarter 2015 Investor Conference Call and webcast at 4:30 p.m., ... it will present at the Credit Suisse 2015 Antibody Conference ... in New York . First ... will cover an update on Merrimack,s progress as well as ...
(Date:4/28/2015)... NUREMBERG , Germany , ... Une résolution plus rapide et plus facile des ... Même une panne temporaire des appareils ... en salle d,opération. Le Ziehm Remote Service offre ... rapides pour un temps de fonctionnement optimisé. Cette ...
(Date:4/28/2015)... ANGELES , April 28, 2015  Illnesses know no ... with our places of business. If you,ve ever woken up ... are as sick as the proverbial dog, or if you,ve ... figure out how to fit it into your schedule, you,ve ... M.D. of House Call Doctor Los Angeles offers an alternative ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Timing of First Quarter 2015 Investor Conference Call and Presentation at Credit Suisse 2015 Antibody Conference 2Ziehm Imaging lance Ziehm Remote Service 2Your Health and Your Schedule Should not be at War 2
... 27, 2011 The Breast journal published ... Seoul National University College of Medicine in Korea that ... for tumor detection compared to whole-body PET/CT when using ... were particularly striking and significant for smaller-sized tumors (less ...
... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) today reported ... Company reported third quarter net sales of $1,031 ... over the third quarter of 2010.  Diluted earnings per share ... increase of 8.3% adjusted over the prior year period. ...
Cached Medicine Technology:Published Data Demonstrates Positron Emission Mammography Has Higher Sensitivity Than PET/CT 2Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 2Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 3Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 4Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 5Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 6Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 7Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 8Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 9Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 10Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 11Zimmer Holdings, Inc. Reports Third Quarter 2011 Financial Results 12
(Date:4/28/2015)... WUHAN, China (PRWEB) April 28, 2015 ... five major municipalities in China that will partner with ... to reduce smoking in a nation that produces more ... the world. , The project, China Tobacco Control Partnership-Tobacco ... whose leaders have shown willingness to support tobacco control ...
(Date:4/28/2015)... April 28, 2015 The popular all-natural ... up for their newly launched L-Style Revolution Program™, and ... and counting in just two short months. The ... and exercise plan for men and women of all ... weight loss and weight maintenance goals faster than traditional ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Brain: The ... American Museum of Natural History, will open at the ... supported by sponsorship from Saint Luke’s Health System. Coming ... City, Toronto, Granada and Milan, this one-of-a-kind exhibition brings ... and technology. , “Saint Luke’s and Museum at ...
(Date:4/28/2015)... 28, 2015 New and more ... more of manufacturers, payers, pharmacists and patients. Now ... journal, is partnering with the National Association of ... dedicated solely to this developing field to better ... growing need. , “This partnership creates a powerful ...
(Date:4/28/2015)... CA (PRWEB) April 28, 2015 ... the Journal of Molecular Imaging and Biology showed ... a 2nd generation fluorine-18 labeled small-molecule PSMA inhibitor. ... Hopkins University in Baltimore, MD by study co-author, ... initial human evaluation of [18F]DCFPyL demonstrated a number ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:Saint Luke's Health System to sponsor Brain: The Inside Story exhibition at Museum at Prairiefire 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 2Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 3Health News:Specialty Pharmacy Times Partners with National Association of Specialty Pharmacy to Improve Care for Patients 4Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3
... 2, 2012 Combination drug therapy may be needed to ... by the Translational Genomics Research Institute (TGen) and Van Andel ... JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell ... the Public Library of Science (PLoS) ONE . ...
... Feb. 2 (HealthDay News) -- The sale of pet turtles ... the small reptiles are still available and continue to infect ... of the health danger, pet turtles are inappropriate pets in ... pregnant women, seniors and those with weak immune systems, according ...
... the most distinctive signs of the development of Alzheimer,s ... protein that neuroscientists call tau. In normal brains, tau ... In the cells of Alzheimer,s brains, by contrast, tau ... These tangles are considered a hallmark of the disease, ...
... Different kinds of lung cancer behave in different ways, ... University of Colorado Cancer Center study published in ... Society, different subgroups of non-small cell lung cancer (NSCLC) ... The study looked at 209 patients diagnosed with ...
... reason the prognosis for metastatic colon cancer has gone from ... Unfortunately, the drug can also carry with it debilitating neurological ... and needles in fingers and toes and can leave patients ... don,t receive the necessary dose to try to keep their ...
... -- A warning to certain types as those Super Bowl ... are more likely to eat too much in social situations, ... pressure to eat when they believe that their eating will ... Exline, a psychologist at Case Western Reserve University, said in ...
Cached Medicine News:Health News:Combination drug therapy urged to battle lung cancer 2Health News:Pet Turtles Carry Salmonella Dangers, CDC Warns 2Health News:Untangling the mysteries of Alzheimer's 2Health News:New research confirms need for lung cancer testing 2Health News:Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer 2Health News:'People Pleasers' More Prone to Overeating: Study 2
It's a slide cabinet system, store up to 54,000 slides in only 2 square feet of space. Ideal for use in Pathology, Cytology, Hematology, Histology, Dermatology, Research, Education....
A slide filing system, allows for the convenient storage and retrieval of microscope slides or transparencies. Requires only 48 cm x 48 cm (19 inches x 19 inches) of floor space....
Unit System Slide Cabinet is constructed from hardwood for long lasting....
... Our moisture resistant, plastic covered ... high, each supporting up to 500 ... weight. Each box accommodates 2000 slides ... your varied storage requirements. Come unassembled ...
Medicine Products: